首页 > 最新文献

Vascular Health and Risk Management最新文献

英文 中文
Assessment of Transserosal Microcirculation with Visible Light Spectroscopy and Laser Doppler Flowmetry in Patients with Median Arcuate Ligament Syndrome and Chronic Mesenteric Ischemia.
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-12 eCollection Date: 2025-01-01 DOI: 10.2147/VHRM.S484787
Gorm von Gohren Edwin, Berit Kristine Bendixen Skraastad, Jonny Hisdal, Torbjørn Wisløff, Jon Otto Sundhagen, Syed Sajid Hussain Kazmi

Introduction: Previous studies with visible light spectroscopy (VLS) and laser Doppler flowmetry (LDF) have shown reduced mucosal circulation of the stomach and duodenal wall in patients with median arcuate ligament syndrome (MALS) and chronic mesenteric ischemia (CMI). However, transserosal microcirculatory assessment during the operative treatment of patients with these conditions has not yet been performed. We aimed to investigate if laparoscopic decompression for MALS and aortomesenteric bypass in CMI can result in immediate measurable increase in the microcirculation in stomach and duodenum.

Patients and methods: In a single center, prospective comparative cohort study, twenty-eight patients suspected of MALS, and eleven with CMI underwent assessment of transserosal microcirculation of stomach and duodenum with Visible Light Spectroscopy (VLS) and Laser Doppler flowmetry (LDF), during surgery. Patients with computed tomography angiography (CTA) verified stenosis grade ≥50% in MALS and ≥70% in CMI were included in the study. Duplex ultrasound (DUS) was performed before and after the surgical treatment. The changes in the pre- and postoperative microcirculation were calculated with paired sample t-test.

Results: VLS showed significant increase in the transserosal relative hemoglobin concentration (rHb) after laparoscopic decompression in patients with MALS (Stomach, before: 58AU±13, after: 62AU±14, p = 0.017) and (Duodenum, before: 62AU±15, after:70AU±15, p = 0.004). Furthermore, a significantly increased blood flow was found in duodenum (Before: 276AU±89, After: 315AU±93, p = 0.015). However, the SaO2 was decreased significantly in the stomach (Before: 86AU±10, After: 82AU±14, p = 0.015), but remained unchanged in the duodenal serosa.The study did not find any increase in the microcirculation of the CMI patients after revascularization. The baseline transserosal microcirculation was indifferent between the groups.

Conclusion: Laparoscopic decompression leads to enhanced transserosal microcirculation in stomach and duodenum in the patients with MALS. The baseline transserosal microcirculation in stomach and duodenum is indifferent in the MALS and CMI.

{"title":"Assessment of Transserosal Microcirculation with Visible Light Spectroscopy and Laser Doppler Flowmetry in Patients with Median Arcuate Ligament Syndrome and Chronic Mesenteric Ischemia.","authors":"Gorm von Gohren Edwin, Berit Kristine Bendixen Skraastad, Jonny Hisdal, Torbjørn Wisløff, Jon Otto Sundhagen, Syed Sajid Hussain Kazmi","doi":"10.2147/VHRM.S484787","DOIUrl":"10.2147/VHRM.S484787","url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies with visible light spectroscopy (VLS) and laser Doppler flowmetry (LDF) have shown reduced mucosal circulation of the stomach and duodenal wall in patients with median arcuate ligament syndrome (MALS) and chronic mesenteric ischemia (CMI). However, transserosal microcirculatory assessment during the operative treatment of patients with these conditions has not yet been performed. We aimed to investigate if laparoscopic decompression for MALS and aortomesenteric bypass in CMI can result in immediate measurable increase in the microcirculation in stomach and duodenum.</p><p><strong>Patients and methods: </strong>In a single center, prospective comparative cohort study, twenty-eight patients suspected of MALS, and eleven with CMI underwent assessment of transserosal microcirculation of stomach and duodenum with Visible Light Spectroscopy (VLS) and Laser Doppler flowmetry (LDF), during surgery. Patients with computed tomography angiography (CTA) verified stenosis grade ≥50% in MALS and ≥70% in CMI were included in the study. Duplex ultrasound (DUS) was performed before and after the surgical treatment. The changes in the pre- and postoperative microcirculation were calculated with paired sample <i>t</i>-test.</p><p><strong>Results: </strong>VLS showed significant increase in the transserosal relative hemoglobin concentration (rHb) after laparoscopic decompression in patients with MALS (Stomach, before: 58AU±13, after: 62AU±14, p = 0.017) and (Duodenum, before: 62AU±15, after:70AU±15, p = 0.004). Furthermore, a significantly increased blood flow was found in duodenum (Before: 276AU±89, After: 315AU±93, p = 0.015). However, the SaO2 was decreased significantly in the stomach (Before: 86AU±10, After: 82AU±14, p = 0.015), but remained unchanged in the duodenal serosa.The study did not find any increase in the microcirculation of the CMI patients after revascularization. The baseline transserosal microcirculation was indifferent between the groups.</p><p><strong>Conclusion: </strong>Laparoscopic decompression leads to enhanced transserosal microcirculation in stomach and duodenum in the patients with MALS. The baseline transserosal microcirculation in stomach and duodenum is indifferent in the MALS and CMI.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"21 ","pages":"61-69"},"PeriodicalIF":2.6,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-05 eCollection Date: 2025-01-01 DOI: 10.2147/VHRM.S499355
Ayman J Hammoudeh, Mo'men Aldalal'ah, Elham A Smadi, Dima Alrishoud, Amal Alomari, Mahmoud Alkhawaldeh, Aseel Rizik, Mahmoud Fakhri Okour, Mohammad Araydah

Background: A growing number of individuals develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of the standard modifiable risk factors (hypertension, diabetes, dyslipidemia, and cigarette smoking) (SMuRF-less patients). Prevalence of SMuRF-less patients in the Middle East has not been studied. This study investigates the prevalence, clinical profiles and outcomes of SMuRF-less patients compared with those who have SMuRFs.

Methods: We analyzed data from 6 published registries and from the Jordan SMuRF-less patients study, including baseline demographic features, cardiovascular risk factors, comorbid diseases, utilization of secondary prevention pharmacotherapy and one year outcome in SMuRF-less patients, those with 1-2 SMuRFs and with 3-4 SMuRFs. Results. A total of f 5540 ASCVD patients were enrolled. Mean age was 57.5 ± 11.6 years, and 1333 (24.1%) were women. Of the whole group, 214 (3.9%) were SMuRF-less, 3014 (54.4%) had 1-2 SMuRFs and 2312 (41.7%) had 3-4 SMuRFs. Compared with the SMuRFs groups, SMuRF-less group were younger, more likely to be men, and had lower prevalence of obesity, physical inactivity, metabolic syndrome, heart failure and chronic kidney disease. SMuRF-less patients were less likely to receive secondary prevention cardiovascular medications (antiplatelet agents, statins, renin angiotensin blockers and beta blockers); all p < 0.001. One year survival in the SMuRF-less patients was significantly lower than that in the SMuRFs groups (97.7% vs.98.4% vs.98.3%, respectively, p = 0.01). Multivariate analysis showed that young age, absence of heart failure and utilization of secondary preventive medications were associated with better one year outcome.

Conclusion: In this cohort of ME patients with ASCVD, nearly four in 100 were SMuRF-less. This rate is lower than that reported by most of published studies, mainly due to the high prevalence of the 4 SMuRFs. SMuRF-less patients were younger, had less comorbid disease, received less secondary prevention pharmacotherapy and had higher rate of one year mortality than those with SMuRFs.

Clinical trials: The study is registered with ClinicalTrials.gov, unique identifier number NCT06199869.

{"title":"Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study.","authors":"Ayman J Hammoudeh, Mo'men Aldalal'ah, Elham A Smadi, Dima Alrishoud, Amal Alomari, Mahmoud Alkhawaldeh, Aseel Rizik, Mahmoud Fakhri Okour, Mohammad Araydah","doi":"10.2147/VHRM.S499355","DOIUrl":"10.2147/VHRM.S499355","url":null,"abstract":"<p><strong>Background: </strong>A growing number of individuals develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of the standard modifiable risk factors (hypertension, diabetes, dyslipidemia, and cigarette smoking) (SMuRF-less patients). Prevalence of SMuRF-less patients in the Middle East has not been studied. This study investigates the prevalence, clinical profiles and outcomes of SMuRF-less patients compared with those who have SMuRFs.</p><p><strong>Methods: </strong>We analyzed data from 6 published registries and from the Jordan SMuRF-less patients study, including baseline demographic features, cardiovascular risk factors, comorbid diseases, utilization of secondary prevention pharmacotherapy and one year outcome in SMuRF-less patients, those with 1-2 SMuRFs and with 3-4 SMuRFs. Results. A total of f 5540 ASCVD patients were enrolled. Mean age was 57.5 ± 11.6 years, and 1333 (24.1%) were women. Of the whole group, 214 (3.9%) were SMuRF-less, 3014 (54.4%) had 1-2 SMuRFs and 2312 (41.7%) had 3-4 SMuRFs. Compared with the SMuRFs groups, SMuRF-less group were younger, more likely to be men, and had lower prevalence of obesity, physical inactivity, metabolic syndrome, heart failure and chronic kidney disease. SMuRF-less patients were less likely to receive secondary prevention cardiovascular medications (antiplatelet agents, statins, renin angiotensin blockers and beta blockers); all p < 0.001. One year survival in the SMuRF-less patients was significantly lower than that in the SMuRFs groups (97.7% vs.98.4% vs.98.3%, respectively, p = 0.01). Multivariate analysis showed that young age, absence of heart failure and utilization of secondary preventive medications were associated with better one year outcome.</p><p><strong>Conclusion: </strong>In this cohort of ME patients with ASCVD, nearly four in 100 were SMuRF-less. This rate is lower than that reported by most of published studies, mainly due to the high prevalence of the 4 SMuRFs. SMuRF-less patients were younger, had less comorbid disease, received less secondary prevention pharmacotherapy and had higher rate of one year mortality than those with SMuRFs.</p><p><strong>Clinical trials: </strong>The study is registered with ClinicalTrials.gov, unique identifier number NCT06199869.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"21 ","pages":"39-50"},"PeriodicalIF":2.6,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual and Cardiovascular health.Factors Influencing on the Quality of Sexual Life of Coronary Heart Disease Patients - a Narrative Review.
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-05 eCollection Date: 2025-01-01 DOI: 10.2147/VHRM.S484566
Magdalena Piegza, Joanna Smolarczyk, Jacek Piegza

Regular sexual activity is comparable to moderate exercise and may be safe for patients with cardiovascular disease (CVD). According to the recommendations of the Princeton III Conference (P3), people with a low risk of adverse cardiac events can undertake sexual activity safely, while other patients must first stabilise their cardiovascular status. Exercise testing is recommended to assess the safety of sexual activity in people with questionable or uncertain cardiac risk (P3). Patients after successful and uncomplicated treatment of myocardial infarction (MI) can return to sexual activity after 3 weeks if the stress test is negative. The 4th Princeton Conference (P4) recommends the use of the 2019 regimen developed by the American College of Cardiology (ACC) and American Heart Association (AHA) to assess the risk of atherosclerotic cardiovascular disease (ASCVD) in men with ED (ACC/AHA ASCVD 2019). Sexual health education plays an important role in the successful return to safe sexual activity, which should include post-MI patients and their relatives. The responsibility for counselling lies with cardiologists, general practitioner (GP) and nursing staff. Sexual rehabilitation should be an integral part of cardiac rehabilitation, and lifestyle modification and optimal treatment of underlying medical conditions are key to maintaining psychophysical well-being and a successful sex life.

{"title":"Sexual and Cardiovascular health.Factors Influencing on the Quality of Sexual Life of Coronary Heart Disease Patients - a Narrative Review.","authors":"Magdalena Piegza, Joanna Smolarczyk, Jacek Piegza","doi":"10.2147/VHRM.S484566","DOIUrl":"10.2147/VHRM.S484566","url":null,"abstract":"<p><p>Regular sexual activity is comparable to moderate exercise and may be safe for patients with cardiovascular disease (CVD). According to the recommendations of the Princeton III Conference (P3), people with a low risk of adverse cardiac events can undertake sexual activity safely, while other patients must first stabilise their cardiovascular status. Exercise testing is recommended to assess the safety of sexual activity in people with questionable or uncertain cardiac risk (P3). Patients after successful and uncomplicated treatment of myocardial infarction (MI) can return to sexual activity after 3 weeks if the stress test is negative. The 4th Princeton Conference (P4) recommends the use of the 2019 regimen developed by the American College of Cardiology (ACC) and American Heart Association (AHA) to assess the risk of atherosclerotic cardiovascular disease (ASCVD) in men with ED (ACC/AHA ASCVD 2019). Sexual health education plays an important role in the successful return to safe sexual activity, which should include post-MI patients and their relatives. The responsibility for counselling lies with cardiologists, general practitioner (GP) and nursing staff. Sexual rehabilitation should be an integral part of cardiac rehabilitation, and lifestyle modification and optimal treatment of underlying medical conditions are key to maintaining psychophysical well-being and a successful sex life.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"21 ","pages":"51-60"},"PeriodicalIF":2.6,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of White Blood Cell Count After Percutaneous Coronary Intervention on Long-Term Prognosis in Patients with Unstable Angina Pectoris: A Single-Center Retrospective Observational Cohort Study. 经皮冠状动脉介入治疗后白细胞计数对不稳定心绞痛患者长期预后的影响:一项单中心回顾性观察队列研究
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-16 eCollection Date: 2025-01-01 DOI: 10.2147/VHRM.S492059
Zhiyuan Zhang, Heyan Wang, Ruiyu Wang, Zeyu She, Xingyue Liang, Huiyi Liu, Xuemeng Kou, Shipeng Wang

Objective: An association between white blood cell count (WBC-C) before percutaneous coronary intervention (PCI) and prognosis has been established in patients undergoing PCI. However, the effect of WBC-C after PCI on the long-term prognosis of patients with unstable angina pectoris (UA) is unclear.

Methods: A retrospective cohort study was conducted in 1811 consecutive patients with UA. The changes of WBC and subgroup counts before and in the early postoperative stages after PCI were observed by paired Wilcoxon signed-rank test. The Kaplan-Meier method and COX proportional regression model were used to evaluate the association between the incidence of 5-year endpoint events and post-PCI leukocytosis.

Results: Leukocytosis and neutrocytosis within 24 hours after PCI were observed in majority of patients with UA, while lymphocyte count significantly decreased after PCI in those patients. There were no significant differences in 5-year all-cause mortality and major adverse cardiovascular and cerebrovascular events (MACCE) between patients in the post-PCI leukocytosis and the control group. However, the 5-year incidence of major adverse cardiovascular events (MACE) was significantly increased in the post-PCI leukocytosis group (p = 0.017, Log rank test). Leukocytosis after PCI was independently associated with the occurrence of MACE (hazard ratio: 1.36; 95% confidence interval: 1.06-1.75; p = 0.015).

Conclusion: Peripheral WBC and neutrophil counts within 24 hours after PCI significantly increased in response to PCI in patients with UA, while lymphocyte count significantly decreased after PCI in those patients. The post-PCI leukocytosis offered predictive value for an increased risk of MACE for up to 5 years in patients with UA.

目的:探讨经皮冠状动脉介入治疗(PCI)患者术前白细胞计数(WBC-C)与预后的关系。然而,PCI术后白细胞计数对不稳定型心绞痛(UA)患者长期预后的影响尚不清楚。方法:对1811例连续UA患者进行回顾性队列研究。采用配对Wilcoxon sign -rank检验观察PCI术前及术后早期WBC及亚组计数的变化。采用Kaplan-Meier法和COX比例回归模型评价5年终点事件发生率与pci术后白细胞增多的关系。结果:多数UA患者PCI术后24小时内出现白细胞增多和中性粒细胞增多,且PCI后淋巴细胞计数明显下降。pci后白细胞增多患者与对照组的5年全因死亡率和主要心脑血管不良事件(MACCE)无显著差异。然而,pci后白细胞增多组5年主要不良心血管事件(MACE)发生率显著升高(p = 0.017, Log rank检验)。PCI术后白细胞增多与MACE的发生独立相关(风险比:1.36;95%置信区间:1.06-1.75;P = 0.015)。结论:UA患者PCI治疗后24小时内外周血白细胞和中性粒细胞计数明显升高,而淋巴细胞计数明显降低。pci后白细胞计数对UA患者5年内MACE风险的增加提供了预测价值。
{"title":"Impact of White Blood Cell Count After Percutaneous Coronary Intervention on Long-Term Prognosis in Patients with Unstable Angina Pectoris: A Single-Center Retrospective Observational Cohort Study.","authors":"Zhiyuan Zhang, Heyan Wang, Ruiyu Wang, Zeyu She, Xingyue Liang, Huiyi Liu, Xuemeng Kou, Shipeng Wang","doi":"10.2147/VHRM.S492059","DOIUrl":"10.2147/VHRM.S492059","url":null,"abstract":"<p><strong>Objective: </strong>An association between white blood cell count (WBC-C) before percutaneous coronary intervention (PCI) and prognosis has been established in patients undergoing PCI. However, the effect of WBC-C after PCI on the long-term prognosis of patients with unstable angina pectoris (UA) is unclear.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted in 1811 consecutive patients with UA. The changes of WBC and subgroup counts before and in the early postoperative stages after PCI were observed by paired Wilcoxon signed-rank test. The Kaplan-Meier method and COX proportional regression model were used to evaluate the association between the incidence of 5-year endpoint events and post-PCI leukocytosis.</p><p><strong>Results: </strong>Leukocytosis and neutrocytosis within 24 hours after PCI were observed in majority of patients with UA, while lymphocyte count significantly decreased after PCI in those patients. There were no significant differences in 5-year all-cause mortality and major adverse cardiovascular and cerebrovascular events (MACCE) between patients in the post-PCI leukocytosis and the control group. However, the 5-year incidence of major adverse cardiovascular events (MACE) was significantly increased in the post-PCI leukocytosis group (p = 0.017, Log rank test). Leukocytosis after PCI was independently associated with the occurrence of MACE (hazard ratio: 1.36; 95% confidence interval: 1.06-1.75; p = 0.015).</p><p><strong>Conclusion: </strong>Peripheral WBC and neutrophil counts within 24 hours after PCI significantly increased in response to PCI in patients with UA, while lymphocyte count significantly decreased after PCI in those patients. The post-PCI leukocytosis offered predictive value for an increased risk of MACE for up to 5 years in patients with UA.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"21 ","pages":"25-37"},"PeriodicalIF":2.6,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11745057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-Care Behavior Based on Knowledge of Patients with Hypertension: A Cross-Sectional Study. 基于高血压患者知识的自我护理行为:一项横断面研究。
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.2147/VHRM.S489688
Eka Afrima Sari, Ristina Mirwanti, Yusshy Kurnia Herliani, Sri Hartati Pratiwi

Background: Adequate self-care behavior is an important factor in controlling hypertension to reduce the number of complications. A patient's knowledge about hypertension can influence their self-care behavior in practice.

Purpose: The aim of this study was to identify self-care behaviors among hypertension patients based on their knowledge.

Patients and methods: This descriptive correlational study was conducted on patients with hypertension in primary care. The sample was selected using purposive sampling, with a one-month data collection period yielding 115 samples. The Hypertension Self-Care Profile instrument was used to assess self-care behavior while the Knowledge on Hypertension instrument was utilized to evaluate knowledge. The characteristics variable was analyzed using descriptive statistics, while the correlation between self-care behavior and knowledge was evaluated using spearman rank correlation.

Results: Most participants had favorable attitudes towards self-care (53%), and they had adequate knowledge about hypertension (53.9%). Patients with favorable behavior and adequate knowledge were 52.5%, while patients with unfavorable behavior and inadequate knowledge were 63.0%. This study found no significant association between self-care behavior and knowledge (p = 0.099, r = 0.155).

Conclusion: Despite most participants demonstrated favorable attitudes and adequate knowledge regarding hypertension self-care, a significant association between these variables was not identified. This suggests that knowledge alone may not be a sufficient predictor of self-care behavior in this population and further research is required to understand the complex factors influencing self-care adherence and develop effective interventions to improve patient outcomes.

背景:充分的自我保健行为是控制高血压、减少并发症发生的重要因素。患者对高血压的认识会影响他们在实践中的自我保健行为。目的:本研究旨在了解高血压患者的自我护理行为。患者和方法:本描述性相关研究对高血压患者进行了初级保健。样本采用有目的抽样,数据收集周期为1个月,共115个样本。采用高血压自我保健量表对自我保健行为进行评估,采用高血压知识量表对知识进行评估。特征变量采用描述性统计分析,自我护理行为与知识的相关性采用spearman秩相关分析。结果:大多数参与者对自我护理有良好的态度(53%),对高血压知识有足够的了解(53.9%)。行为良好、知识充分者占52.5%,行为不良、知识不充分者占63.0%。本研究未发现自我护理行为与自我护理知识有显著相关(p = 0.099, r = 0.155)。结论:尽管大多数参与者对高血压自我保健表现出良好的态度和足够的知识,但这些变量之间的显著关联尚未确定。这表明,知识本身可能并不能充分预测这一人群的自我护理行为,需要进一步的研究来了解影响自我护理依从性的复杂因素,并制定有效的干预措施来改善患者的预后。
{"title":"Self-Care Behavior Based on Knowledge of Patients with Hypertension: A Cross-Sectional Study.","authors":"Eka Afrima Sari, Ristina Mirwanti, Yusshy Kurnia Herliani, Sri Hartati Pratiwi","doi":"10.2147/VHRM.S489688","DOIUrl":"10.2147/VHRM.S489688","url":null,"abstract":"<p><strong>Background: </strong>Adequate self-care behavior is an important factor in controlling hypertension to reduce the number of complications. A patient's knowledge about hypertension can influence their self-care behavior in practice.</p><p><strong>Purpose: </strong>The aim of this study was to identify self-care behaviors among hypertension patients based on their knowledge.</p><p><strong>Patients and methods: </strong>This descriptive correlational study was conducted on patients with hypertension in primary care. The sample was selected using purposive sampling, with a one-month data collection period yielding 115 samples. The Hypertension Self-Care Profile instrument was used to assess self-care behavior while the Knowledge on Hypertension instrument was utilized to evaluate knowledge. The characteristics variable was analyzed using descriptive statistics, while the correlation between self-care behavior and knowledge was evaluated using spearman rank correlation.</p><p><strong>Results: </strong>Most participants had favorable attitudes towards self-care (53%), and they had adequate knowledge about hypertension (53.9%). Patients with favorable behavior and adequate knowledge were 52.5%, while patients with unfavorable behavior and inadequate knowledge were 63.0%. This study found no significant association between self-care behavior and knowledge (p = 0.099, r = 0.155).</p><p><strong>Conclusion: </strong>Despite most participants demonstrated favorable attitudes and adequate knowledge regarding hypertension self-care, a significant association between these variables was not identified. This suggests that knowledge alone may not be a sufficient predictor of self-care behavior in this population and further research is required to understand the complex factors influencing self-care adherence and develop effective interventions to improve patient outcomes.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"21 ","pages":"17-24"},"PeriodicalIF":2.6,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Scoping Review of Factors Associated with Delayed Extubation in Post Cardiac Surgery Patients. 心脏手术后患者延迟拔管相关因素的范围综述。
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-08 eCollection Date: 2025-01-01 DOI: 10.2147/VHRM.S479352
Regina Indah Kumalasari, Cecep Eli Kosasih, Ayu Prawesti Priambodo

Background: Delayed extubation (DE) after cardiac surgery is associated with high morbidity, mortality, increased length of stay in the intensive care unit, and hospital costs. Various studies have identified factors that influence the occurrence of DE in patients after cardiac surgery, but no review has systematically synthesized the results.

Purpose: This review aimed to identify the influencing factors and the leading causes of DE in patients after cardiac surgery.

Methods: This scoping review uses the framework developed by Arksey and O'Malley (2005). Literature was searched through four databases: PubMed, Scopus, Science Direct, and CINAHL, and two search engines, Sage and Google Scholar, accessed on October 20, 2024. The articles analyzed met the inclusion criteria, such as full-text articles in English, published from 2014-2024, with case-control, cross-sectional, longitudinal, and cohort study designs and had good quality as assessed using the Joanna Briggs Institute critical appraisal checklist. Data was synthesized using thematic analysis.

Results: Eight articles with a total of 13801 participants were included in this review. The prevalence of DE after cardiac surgery ranged from 13.6% to 91.9%. The factors affecting DE were categorized into preoperative, intraoperative and postoperative. The factors most commonly reported to influence ED include preoperative factors (age ≥ 60 and EF < 50%), intraoperative factors (duration of surgery ≥7 hours, use of IABP and sedatives), and postoperative factors (BNP≥806 pg/mL). The leading causes of DE after cardiac surgery are hemodynamic instability requiring increased inotropes (33.51%), reduced level of consciousness or drowsiness (31.91%), and postoperative bleeding (20.74%).

Conclusion: The process of extubation is a crucial phase in postoperative care. By comprehending the elements that impact DE, healthcare providers can effectively allocate medical resources to enhance the success of weaning, extubation, and recovery following cardiac surgery. Consequently, further research focusing on DE is essential, particularly in patients who have undergone cardiac surgery.

背景:心脏手术后延迟拔管(DE)与高发病率、高死亡率、重症监护室住院时间延长和住院费用有关。目的:本综述旨在确定心脏手术后患者延迟拔管的影响因素和主要原因:本综述采用 Arksey 和 O'Malley(2005 年)制定的框架。通过四个数据库对文献进行了检索:PubMed、Scopus、Science Direct 和 CINAHL,以及 Sage 和 Google Scholar 两个搜索引擎,访问时间为 2024 年 10 月 20 日。所分析的文章均符合纳入标准,如英文全文,发表于 2014-2024 年间,采用病例对照、横断面、纵向和队列研究设计,并使用乔安娜-布里格斯研究所的关键评估核对表进行了质量评估。采用专题分析法对数据进行了综合:本综述共收录了 8 篇文章,共有 13801 名参与者。心脏手术后 DE 的发生率从 13.6% 到 91.9% 不等。影响ED的因素分为术前、术中和术后。最常见的影响ED的因素包括术前因素(年龄≥60岁和EF<50%)、术中因素(手术时间≥7小时、使用IABP和镇静剂)和术后因素(BNP≥806 pg/mL)。心脏手术后导致拔管的主要原因是血流动力学不稳定,需要增加肌力(33.51%)、意识水平下降或嗜睡(31.91%)和术后出血(20.74%):结论:拔管过程是术后护理的关键阶段。通过了解影响拔管的因素,医护人员可以有效地分配医疗资源,提高心脏手术后断奶、拔管和康复的成功率。因此,有必要进一步开展以拔管为重点的研究,尤其是针对心脏手术患者的研究。
{"title":"A Scoping Review of Factors Associated with Delayed Extubation in Post Cardiac Surgery Patients.","authors":"Regina Indah Kumalasari, Cecep Eli Kosasih, Ayu Prawesti Priambodo","doi":"10.2147/VHRM.S479352","DOIUrl":"10.2147/VHRM.S479352","url":null,"abstract":"<p><strong>Background: </strong>Delayed extubation (DE) after cardiac surgery is associated with high morbidity, mortality, increased length of stay in the intensive care unit, and hospital costs. Various studies have identified factors that influence the occurrence of DE in patients after cardiac surgery, but no review has systematically synthesized the results.</p><p><strong>Purpose: </strong>This review aimed to identify the influencing factors and the leading causes of DE in patients after cardiac surgery.</p><p><strong>Methods: </strong>This scoping review uses the framework developed by Arksey and O'Malley (2005). Literature was searched through four databases: PubMed, Scopus, Science Direct, and CINAHL, and two search engines, Sage and Google Scholar, accessed on October 20, 2024. The articles analyzed met the inclusion criteria, such as full-text articles in English, published from 2014-2024, with case-control, cross-sectional, longitudinal, and cohort study designs and had good quality as assessed using the Joanna Briggs Institute critical appraisal checklist. Data was synthesized using thematic analysis.</p><p><strong>Results: </strong>Eight articles with a total of 13801 participants were included in this review. The prevalence of DE after cardiac surgery ranged from 13.6% to 91.9%. The factors affecting DE were categorized into preoperative, intraoperative and postoperative. The factors most commonly reported to influence ED include preoperative factors (age ≥ 60 and EF < 50%), intraoperative factors (duration of surgery ≥7 hours, use of IABP and sedatives), and postoperative factors (BNP≥806 pg/mL). The leading causes of DE after cardiac surgery are hemodynamic instability requiring increased inotropes (33.51%), reduced level of consciousness or drowsiness (31.91%), and postoperative bleeding (20.74%).</p><p><strong>Conclusion: </strong>The process of extubation is a crucial phase in postoperative care. By comprehending the elements that impact DE, healthcare providers can effectively allocate medical resources to enhance the success of weaning, extubation, and recovery following cardiac surgery. Consequently, further research focusing on DE is essential, particularly in patients who have undergone cardiac surgery.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"21 ","pages":"1-15"},"PeriodicalIF":2.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Differences in the Impact of BMI on Length of Hospital Stay in Hypertensive Patients Admitted to a Cardiology Department: A Retrospective Cohort Study. BMI对心内科高血压患者住院时间影响的性别差异:一项回顾性队列研究
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-24 eCollection Date: 2024-01-01 DOI: 10.2147/VHRM.S490795
Katarzyna Łokieć, Bartosz Uchmanowicz, Adrian Kwaśny, Grzegorz Kubielas, Jacek Smereka, Stanisław Surma, Anthony Dissen, Michał Czapla

Background and purpose: Body mass index (BMI), as a straightforward measure, is widely used in clinical practice, and its results are linked to HT and patient prognosis. This study aimed to ascertain if sex differences exist in the prognostic significance of BMI at the time of admission to the cardiology unit, and how this impacts the LOHS for patients suffering from hypertension.

Patients and methods: A retrospective analysis of the medical records of 486 patients admitted urgently with a diagnosis of HT to the Cardiology Department at University Hospital in Wroclaw (Poland) between January 2017 and June 2021 was conducted.

Results: Women accounted for 53% of the study group and were older than men (64.7±12.8 vs 60.5±11.8, p=0.466). The mean BMI in women was 28.49±5.39 and in men 29.14±4.88. In an unadjusted linear regression model BMI results were not independent predictors of LOHS in either sex. After adjusting the model for comorbidities and blood test results, significant independent predictors of LOHS in women were LDL (B=-0.02, p<0.001), HDL (B=-0.043, p=0.012), TC (B=0.015, p=0.007), and hsCRP (B=0.02, p=0.013), while in men they were LDL (B= -0.026, p<0.001), HDL (B= -0.058, p=0.003), and TC (B=0.022, p=0.002).

Conclusions: The result of BMI assessed at the time of a patient's admission to the cardiology department is not a significant predictor of LOHS in both men and women with hypertension.

背景与目的:身体质量指数(Body mass index, BMI)作为一种直观的测量指标被广泛应用于临床实践,其结果与HT和患者预后有关。本研究旨在确定在入住心脏科时BMI的预后意义是否存在性别差异,以及性别差异如何影响高血压患者的LOHS。患者和方法:回顾性分析了2017年1月至2021年6月在波兰弗罗茨瓦夫大学医院心内科急诊诊断为HT的486例患者的医疗记录。结果:女性占研究组的53%,年龄大于男性(64.7±12.8 vs 60.5±11.8,p=0.466)。女性的平均BMI为28.49±5.39,男性为29.14±4.88。在未调整的线性回归模型中,BMI结果不是男女LOHS的独立预测因子。在调整了合并症和血液检查结果的模型后,低密度脂蛋白(LDL)是女性LOHS的重要独立预测因子(B=-0.02, p)。结论:患者入院时的BMI评估结果并不是男性和女性高血压患者LOHS的重要预测因子。
{"title":"Sex Differences in the Impact of BMI on Length of Hospital Stay in Hypertensive Patients Admitted to a Cardiology Department: A Retrospective Cohort Study.","authors":"Katarzyna Łokieć, Bartosz Uchmanowicz, Adrian Kwaśny, Grzegorz Kubielas, Jacek Smereka, Stanisław Surma, Anthony Dissen, Michał Czapla","doi":"10.2147/VHRM.S490795","DOIUrl":"10.2147/VHRM.S490795","url":null,"abstract":"<p><strong>Background and purpose: </strong>Body mass index (BMI), as a straightforward measure, is widely used in clinical practice, and its results are linked to HT and patient prognosis. This study aimed to ascertain if sex differences exist in the prognostic significance of BMI at the time of admission to the cardiology unit, and how this impacts the LOHS for patients suffering from hypertension.</p><p><strong>Patients and methods: </strong>A retrospective analysis of the medical records of 486 patients admitted urgently with a diagnosis of HT to the Cardiology Department at University Hospital in Wroclaw (Poland) between January 2017 and June 2021 was conducted.</p><p><strong>Results: </strong>Women accounted for 53% of the study group and were older than men (64.7±12.8 vs 60.5±11.8, p=0.466). The mean BMI in women was 28.49±5.39 and in men 29.14±4.88. In an unadjusted linear regression model BMI results were not independent predictors of LOHS in either sex. After adjusting the model for comorbidities and blood test results, significant independent predictors of LOHS in women were LDL (B=-0.02, p<0.001), HDL (B=-0.043, p=0.012), TC (B=0.015, p=0.007), and hsCRP (B=0.02, p=0.013), while in men they were LDL (B= -0.026, p<0.001), HDL (B= -0.058, p=0.003), and TC (B=0.022, p=0.002).</p><p><strong>Conclusions: </strong>The result of BMI assessed at the time of a patient's admission to the cardiology department is not a significant predictor of LOHS in both men and women with hypertension.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"20 ","pages":"579-591"},"PeriodicalIF":2.6,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracerebral Hemorrhage with Churg Strauss-Syndrome: Multidisciplinary Collaboration and Literature Review. 脑出血伴Churg - strauss - strauss综合征:多学科合作和文献综述。
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-14 eCollection Date: 2024-01-01 DOI: 10.2147/VHRM.S489212
Pu Bai, Peitao Xie

Objective: To explore the clinical characteristics and treatment outcomes of intracerebral hemorrhage in eosinophilic granulomatosis with polyangiitis (EGPA).

Methods and patient presentation: We report an 18-year-old student of EGPA complicated with intracerebral hemorrhage. The laboratory tests showed a continuous increase in eosinophils. The CT of head and chest showed cerebral hemorrhage and pulmonary infiltration.

Interventions: The patient received an intravenous infusion of methylprednisolone 1g/(kg·d) and cyclophosphamide for 3 days, followed by oral prednisone 1 mg/(kg·d).

Outcomes: At discharge, the patient's head and chest CT showed obvious absorption of intracranial hematoma and improvement of pulmonary infiltration. We reviewed 40 previously published cases of EGPA with intracerebral hemorrhage focusing on the clinical features and treatment of intracerebral hemorrhage caused by EGPA.

Conclusion: For the cases of EGPA complicated with intracerebral hemorrhage, we should timely differentiate diagnosis and recognition. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients EGPA with intracerebral hemorrhage. When a patient is affected by EGPA, it is essential to remain vigilant for signs of Central Nervous System involvement. The treatment with glucocorticoids and cyclophosphamide is effective in managing EGPA.

目的:探讨嗜酸性肉芽肿病合并多血管炎(EGPA)并发脑出血的临床特点及治疗效果。方法和患者表现:我们报告了一例18岁的EGPA学生并发脑出血。实验室检查显示嗜酸性粒细胞持续增加。头部及胸部CT示脑出血及肺部浸润。干预措施:甲泼尼龙1g/(kg·d)、环磷酰胺静脉滴注3天,强的松1mg /(kg·d)口服。出院时,患者头部及胸部CT显示颅内血肿明显吸收,肺部浸润改善。我们回顾了以往发表的40例EGPA合并脑出血的病例,重点介绍了EGPA引起脑出血的临床特点和治疗方法。结论:对于EGPA合并脑出血的病例,应及时鉴别诊断和识别。早期诊断和积极的免疫抑制治疗有助于改善EGPA合并脑出血患者的预后。当患者受到EGPA的影响时,必须对中枢神经系统受累的迹象保持警惕。糖皮质激素和环磷酰胺治疗EGPA是有效的。
{"title":"Intracerebral Hemorrhage with Churg Strauss-Syndrome: Multidisciplinary Collaboration and Literature Review.","authors":"Pu Bai, Peitao Xie","doi":"10.2147/VHRM.S489212","DOIUrl":"10.2147/VHRM.S489212","url":null,"abstract":"<p><strong>Objective: </strong>To explore the clinical characteristics and treatment outcomes of intracerebral hemorrhage in eosinophilic granulomatosis with polyangiitis (EGPA).</p><p><strong>Methods and patient presentation: </strong>We report an 18-year-old student of EGPA complicated with intracerebral hemorrhage. The laboratory tests showed a continuous increase in eosinophils. The CT of head and chest showed cerebral hemorrhage and pulmonary infiltration.</p><p><strong>Interventions: </strong>The patient received an intravenous infusion of methylprednisolone 1g/(kg·d) and cyclophosphamide for 3 days, followed by oral prednisone 1 mg/(kg·d).</p><p><strong>Outcomes: </strong>At discharge, the patient's head and chest CT showed obvious absorption of intracranial hematoma and improvement of pulmonary infiltration. We reviewed 40 previously published cases of EGPA with intracerebral hemorrhage focusing on the clinical features and treatment of intracerebral hemorrhage caused by EGPA.</p><p><strong>Conclusion: </strong>For the cases of EGPA complicated with intracerebral hemorrhage, we should timely differentiate diagnosis and recognition. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients EGPA with intracerebral hemorrhage. When a patient is affected by EGPA, it is essential to remain vigilant for signs of Central Nervous System involvement. The treatment with glucocorticoids and cyclophosphamide is effective in managing EGPA.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"20 ","pages":"567-578"},"PeriodicalIF":2.6,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11653849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between the Hemoglobin-to-Red Cell Distribution Width Ratio and in-Hospital Mortality in Patients with Chronic Heart Failure. 慢性心力衰竭患者血红蛋白与红细胞分布宽度比与住院死亡率的关系
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-10 eCollection Date: 2024-01-01 DOI: 10.2147/VHRM.S486075
Ying Li, Chunlin Xu, Zuoan Qin, Liangqing Ge

Purpose: Hemoglobin (Hb) levels and red cell distribution width (RDW) are standard and widely used parameters that predict clinical outcomes in patients with chronic heart failure (CHF). The Hb to RDW ratio (HRR) provides an incremental clinical prediction, as it reflects the various clinical characteristics of patients. No published data exists in the Medical Information Mart for Intensive Care (MIMIC-IV) and eICU Collaborative Research Database (eICU-CRD) databases on HRR and its association with in-hospital mortality among patients with CHF. The aim of this study was to evaluate the relationship between the HRR and in-hospital mortality in two large real-world cohorts of patients with chronic CHF.

Patients and methods: Data from the MIMIC-IV and eICU-CRD databases were used to explore the association between HRR and in-hospital mortality. Multivariate logistic regression, stratified analysis with interaction, and restricted cubic splines were used to investigate the association between HRR and in-hospital mortality.

Results:  A total of 30,411 patients with CHF were enrolled based on the MIMIC-IV and multicenter eICU-CRD databases (15,983 and 14,428, respectively), including 16,295 men and 14,116 women with a median age of 73 years. The mean HRR was 0.69 ± 0.20. The overall in-hospital mortality rate was 12.63%. Increasing quantiles of HRR were associated with reduced in-hospital mortality rates. After adjusting for significant predictors, multivariate logistic regression analysis demonstrated that a low HRR was a significant predictor of in-hospital mortality, with a graded reduction in risk as HRR increased. Sensitivity analysis using restricted cubic splines demonstrated a continuous increase in in-hospital mortality risk with decreasing HRR (P = 0.262 for the non-linear model).

Conclusion: A linear relationship was observed between baseline HRR levels and in-hospital mortality. Lower HRR levels were associated with higher in-hospital mortality in patients with CHF. HRR could be a reliable clinical metric for assessing in-hospital mortality risk.

目的:血红蛋白(Hb)水平和红细胞分布宽度(RDW)是预测慢性心力衰竭(CHF)患者临床结局的标准和广泛使用的参数。Hb / RDW比值(HRR)反映了患者的各种临床特征,提供了一种渐进的临床预测。重症监护医学信息市场(MIMIC-IV)和eICU合作研究数据库(eICU- crd)数据库中没有关于HRR及其与CHF患者住院死亡率关系的已发表数据。本研究的目的是评估两个大型现实世界慢性慢性心力衰竭患者队列中HRR与住院死亡率之间的关系。患者和方法:使用来自MIMIC-IV和eICU-CRD数据库的数据来探讨HRR与院内死亡率之间的关系。采用多变量logistic回归、相互作用分层分析和限制三次样条来研究HRR与住院死亡率之间的关系。结果:根据MIMIC-IV和多中心eICU-CRD数据库,共有30,411例CHF患者入组(分别为15,983例和14,428例),其中男性16,295例,女性14,116例,中位年龄为73岁。平均HRR为0.69±0.20。住院总死亡率为12.63%。HRR分位数的增加与院内死亡率的降低有关。在调整了重要的预测因子后,多变量逻辑回归分析表明,低HRR是院内死亡率的重要预测因子,随着HRR的增加,风险逐渐降低。使用受限三次样条的敏感性分析显示,随着HRR的降低,住院死亡风险持续增加(非线性模型的P = 0.262)。结论:基线HRR水平与住院死亡率之间存在线性关系。较低的HRR水平与CHF患者较高的住院死亡率相关。HRR可作为评估院内死亡风险的可靠临床指标。
{"title":"Relationship Between the Hemoglobin-to-Red Cell Distribution Width Ratio and in-Hospital Mortality in Patients with Chronic Heart Failure.","authors":"Ying Li, Chunlin Xu, Zuoan Qin, Liangqing Ge","doi":"10.2147/VHRM.S486075","DOIUrl":"10.2147/VHRM.S486075","url":null,"abstract":"<p><strong>Purpose: </strong>Hemoglobin (Hb) levels and red cell distribution width (RDW) are standard and widely used parameters that predict clinical outcomes in patients with chronic heart failure (CHF). The Hb to RDW ratio (HRR) provides an incremental clinical prediction, as it reflects the various clinical characteristics of patients. No published data exists in the Medical Information Mart for Intensive Care (MIMIC-IV) and eICU Collaborative Research Database (eICU-CRD) databases on HRR and its association with in-hospital mortality among patients with CHF. The aim of this study was to evaluate the relationship between the HRR and in-hospital mortality in two large real-world cohorts of patients with chronic CHF.</p><p><strong>Patients and methods: </strong>Data from the MIMIC-IV and eICU-CRD databases were used to explore the association between HRR and in-hospital mortality. Multivariate logistic regression, stratified analysis with interaction, and restricted cubic splines were used to investigate the association between HRR and in-hospital mortality.</p><p><strong>Results: </strong> A total of 30,411 patients with CHF were enrolled based on the MIMIC-IV and multicenter eICU-CRD databases (15,983 and 14,428, respectively), including 16,295 men and 14,116 women with a median age of 73 years. The mean HRR was 0.69 ± 0.20. The overall in-hospital mortality rate was 12.63%. Increasing quantiles of HRR were associated with reduced in-hospital mortality rates. After adjusting for significant predictors, multivariate logistic regression analysis demonstrated that a low HRR was a significant predictor of in-hospital mortality, with a graded reduction in risk as HRR increased. Sensitivity analysis using restricted cubic splines demonstrated a continuous increase in in-hospital mortality risk with decreasing HRR (P = 0.262 for the non-linear model).</p><p><strong>Conclusion: </strong>A linear relationship was observed between baseline HRR levels and in-hospital mortality. Lower HRR levels were associated with higher in-hospital mortality in patients with CHF. HRR could be a reliable clinical metric for assessing in-hospital mortality risk.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"20 ","pages":"553-565"},"PeriodicalIF":2.6,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11645964/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Lactate with Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study. 乳酸与心血管疾病风险的关联:一项双样本孟德尔随机研究
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.2147/VHRM.S488424
Xindi Chang, Wang Zheng, Yingli Zhao, Wangkang Niku, Bing Deng, Ping Liu, Yiru Wang

Purpose: Studies consistently show abnormally high levels of lactate acid in cardiovascular disease patients, suggested that targeting lactate production may serve as potential strategies for the treatment in the future. However, observational results may be subject to residual confounding and bias.

Methods: This study used the dataset from GWAS database to examine confounding in epidemiologic associations between lactate and cardiovascular diseases. A genome-wide genetic association study using Mendelian randomization (MR) was performed from December 02, 2023 to January 15, 2024 to reduce confounding and enhance causal inference. Primary analysis was conducted using inverse-variance-weighted MR. All studies included patients predominantly of European ancestry.

Results: The association between lactate and cardiovascular diseases, including 60801 cases from coronary heart disease, 7018 cases from myocardial infarction, 14334 cases from coronary atherosclerosis, 60620 cases from atrial fibrillation, 54358 cases from hypertension, 71 cases from hypertrophic cardiomyopathy, 47309 cases from heart failure, 7055 cases from stroke, 7193 cases from cardioembolic ischemic stroke, 4373 cases from ischemic stroke caused by large vascular atherosclerosis, 2118 cases from pulmonary embolism, 1230 cases from peripheral artery disease, and 4620 cases from venous thromboembolism. Genetically predicted coronary atherosclerosis was associated with a higher risk of lactate level (OR = 1.950; 95% CI (0.087, 1.249); P = 0.024); this association was also evident for peripheral artery disease (OR = 1.003; 95% CI (0.000, 0.005); P = 0.021). No genetically predicted associations were noted for the other cardiovascular diseases.

Conclusion: The findings of this study provide genetic evidence supporting a higher risk of lactate level only in coronary atherosclerosis and peripheral artery disease. However, no genetic association between lactate level and the other cardiovascular diseases.

目的:研究一致表明心血管疾病患者乳酸水平异常高,提示靶向乳酸生成可能是未来治疗的潜在策略。然而,观察结果可能存在残留混淆和偏倚。方法:本研究使用GWAS数据库的数据集来检查乳酸与心血管疾病之间流行病学关联的混淆。为了减少混杂和增强因果推理,研究人员于2023年12月2日至2024年1月15日使用孟德尔随机化(MR)进行了全基因组遗传关联研究。主要分析采用反方差加权mr进行,所有研究主要包括欧洲血统的患者。结果:冠心病60801例、心肌梗死7018例、冠状动脉粥样硬化14334例、房颤60620例、高血压54358例、肥厚性心肌病71例、心力衰竭47309例、脑卒中7055例、心栓性缺血性脑卒中7193例、大血管动脉粥样硬化缺血性脑卒中4373例。肺栓塞2118例,外周动脉病变1230例,静脉血栓栓塞4620例。基因预测的冠状动脉粥样硬化与乳酸水平升高的风险相关(OR = 1.950;95% ci (0.087, 1.249);P = 0.024);外周动脉疾病也有明显的相关性(OR = 1.003;95% ci (0.000, 0.005);P = 0.021)。其他心血管疾病没有遗传预测关联。结论:本研究的发现提供了遗传证据,支持乳酸水平仅在冠状动脉粥样硬化和外周动脉疾病中具有较高的风险。然而,乳酸水平与其他心血管疾病之间没有遗传关联。
{"title":"Association of Lactate with Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study.","authors":"Xindi Chang, Wang Zheng, Yingli Zhao, Wangkang Niku, Bing Deng, Ping Liu, Yiru Wang","doi":"10.2147/VHRM.S488424","DOIUrl":"10.2147/VHRM.S488424","url":null,"abstract":"<p><strong>Purpose: </strong>Studies consistently show abnormally high levels of lactate acid in cardiovascular disease patients, suggested that targeting lactate production may serve as potential strategies for the treatment in the future. However, observational results may be subject to residual confounding and bias.</p><p><strong>Methods: </strong>This study used the dataset from GWAS database to examine confounding in epidemiologic associations between lactate and cardiovascular diseases. A genome-wide genetic association study using Mendelian randomization (MR) was performed from December 02, 2023 to January 15, 2024 to reduce confounding and enhance causal inference. Primary analysis was conducted using inverse-variance-weighted MR. All studies included patients predominantly of European ancestry.</p><p><strong>Results: </strong>The association between lactate and cardiovascular diseases, including 60801 cases from coronary heart disease, 7018 cases from myocardial infarction, 14334 cases from coronary atherosclerosis, 60620 cases from atrial fibrillation, 54358 cases from hypertension, 71 cases from hypertrophic cardiomyopathy, 47309 cases from heart failure, 7055 cases from stroke, 7193 cases from cardioembolic ischemic stroke, 4373 cases from ischemic stroke caused by large vascular atherosclerosis, 2118 cases from pulmonary embolism, 1230 cases from peripheral artery disease, and 4620 cases from venous thromboembolism. Genetically predicted coronary atherosclerosis was associated with a higher risk of lactate level (OR = 1.950; 95% CI (0.087, 1.249); <i>P</i> = 0.024); this association was also evident for peripheral artery disease (OR = 1.003; 95% CI (0.000, 0.005); <i>P</i> = 0.021). No genetically predicted associations were noted for the other cardiovascular diseases.</p><p><strong>Conclusion: </strong>The findings of this study provide genetic evidence supporting a higher risk of lactate level only in coronary atherosclerosis and peripheral artery disease. However, no genetic association between lactate level and the other cardiovascular diseases.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"20 ","pages":"541-551"},"PeriodicalIF":2.6,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular Health and Risk Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1